Literature DB >> 6311396

Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence.

E E Lack, C Neave, G F Vawter.   

Abstract

The clinical and pathologic features of 32 children and adolescents with hepatocellular carcinoma (HCC) are reviewed. Their average age at diagnosis was 9.7 years (range, 5 months to 21 years) and there was a slight predilection for males in a ratio of 1.7 to one. Of eight patients with associated or underlying abnormalities, five had cirrhosis, two had an antecedent (or coexisting) tumor fulfilling pathologic criteria for hepatic adenoma, and one developed HCC ten years after nephrectomy and radiation therapy for a Wilms' tumor. Our data reaffirm the high mortality associated with HCC (91%). Three of five tumors classified as fibrolamellar type were amenable to surgical resection while only 15% of the remaining HCC were operable. The average duration of disease for patients with conventional HCC was 4.2 months, while those with the fibrolamellar variant had a more lingering course (average, 28.5 months). Available data indicate that the fibrolamellar variant should be distinguished from HCC with more conventional histology because of greater resectability and improved overall survival.

Entities:  

Mesh:

Year:  1983        PMID: 6311396     DOI: 10.1002/1097-0142(19831015)52:8<1510::aid-cncr2820520830>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

1.  Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.

Authors:  A D Pinna; S Iwatsuki; R G Lee; S Todo; J R Madariaga; J W Marsh; A Casavilla; I Dvorchik; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

2.  Clinicopathological features and outcomes of young patients with hepatocellular carcinoma after hepatectomy.

Authors:  Kazuki Takeishi; Ken Shirabe; Jun Muto; Takeo Toshima; Akinobu Taketomi; Yoshihiko Maehara
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

Review 3.  [Hepatocellular adenoma. Malignancy potential and differentiation from hepatocellular carcinoma].

Authors:  P Flemming; U Lehmann; D Steinemann; H Kreipe; L Wilkens
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

Review 4.  Fibrolamellar hepatocellular carcinoma. Case reports and a review of the literature.

Authors:  S Saab; F Yao
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

Review 5.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Late supra-diaphragmatic lymph node recurrence following resection of a fibrolamellar hepatocarcinoma: an unusual case.

Authors:  Basile Tsilividis; Emmanuel Huet; Jean Lubrano; Laurence Lacaze; Jean Pierre Lestrat; Arnaud François; Ghassan Riachi; Michel Scotté
Journal:  Surg Radiol Anat       Date:  2009-09-24       Impact factor: 1.246

7.  Recurrent obstructive jaundice caused by fibrolamellar hepatocellular carcinoma.

Authors:  J S Albaugh; E B Keeffe; W W Krippaehne
Journal:  Dig Dis Sci       Date:  1984-08       Impact factor: 3.199

8.  Pregnancy in a patient with fibrolamellar hepatocellular carcinoma.

Authors:  O Gemer; S Segal; E Zohav
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

Review 9.  Fibrolamellar hepatocellular carcinoma coexistent with a hepatocellular carcinoma of common type: report of a case.

Authors:  K Okada; Y I Kim; K Nakashima; I Tada; T Yoshida; M Kobayashi; S Yokoyama
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  Fibrolamellar carcinoma of the liver--a case report.

Authors:  T Imai; H Yokoi; T Noguchi; Y Kawarada; R Mizumoto
Journal:  Gastroenterol Jpn       Date:  1991-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.